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Immune surveillance and host defense depend on
the precisely regulated trafficking of lymphocytes.
Integrin a4b7 mediates lymphocyte homing to the
gut through its interaction with mucosal vascular
address in cell adhesion molecule-1 (MAdCAM-1).
a4b7 also binds vascular cell adhesion molecule-1
(VCAM-1), which is expressed in other tissues. To
maintain the tissue specificity of lymphocyte homing,
a4b7 must distinguish one ligand from the other.
Here, we demonstrate that a4b7 is activated by
different chemokines in a ligand-specific manner.
CCL25 stimulation promotes a4b7-mediated lympho-
cyte adhesion to MAdCAM-1 but suppresses adhe-
sion to VCAM-1, whereas CXCL10 stimulation has
the opposite effect. Using separate pathways,
CCL25 and CXCL10 stimulate differential phosphor-
ylation states of the b7 tail and distinct talin and
kindlin-3 binding patterns, resulting in different
binding affinities of MAdCAM-1 and VCAM-1 to
a4b7. Thus, our findings provide a mechanism
for lymphocyte traffic control through the unique
ligand-specific regulation of integrin adhesion by
different chemokines.
INTRODUCTION
The control of systemic immune responses depends on the pre-
cisely regulated trafficking of lymphocytes from blood into
different tissues (Butcher and Picker, 1996). The exquisite spec-
ificity of tissue-specific lymphocyte homing is mediated by the
tightly controlled adhesion of lymphocytes to the vascular endo-
thelium at target sites (Kunkel and Butcher, 2002). Lymphocytes
express unique patterns of homing molecules, and the vascular
endothelia in different tissues express the specific ligands (Mora
and von Andrian, 2006). The interactions between homing mole-
cules and their ligands enable lymphocytes to target to different
tissues through a multistep process governed by selectins,
integrins, and chemoattractants (Hartmann et al., 2008). Lym-Dphocytes initially tether and roll on the endothelium by transiently
interacting with endothelial cells via selectins and some integ-
rins. Then integrins on lymphocytes become activated by che-
moattractants presented on the endothelium, which is a key
step in the recruitment of specific lymphocytes from blood to
target tissues. Chemokines activate integrins through rapidly
triggering an inside-out signaling that regulates the binding of
intracellular effector proteins (e.g., talin and kindlin) to integrin
cytoplasmic domains (Kinashi, 2005), which induces the conver-
sion of inactive integrin in a bent conformation into its active form
with an extended structure (Takagi et al., 2002).
Most integrins expressed on lymphocytes recognize multiple
ligands (Humphries et al., 2006). Integrin a4b7 is a homing recep-
tor that targets lymphocytes in the bloodstream to mucosal tis-
sues, especially the gut (Cox et al., 2010). The primary ligand
for a4b7 is mucosal vascular address in cell adhesion mole-
cule-1 (MAdCAM-1), which is specifically expressed on the
endothelium of high endothelial venules in the gut and gut-asso-
ciated lymphoid tissues, such as Peyer’s patches and mesen-
teric lymph nodes (mLNs; Berlin et al., 1995). Another ligand
for a4b7, vascular cell adhesion molecule-1 (VCAM-1), is widely
expressed on stimulated endothelial cells of blood vessels, pe-
ripheral lymph nodes (pLNs), and bone marrow (Berlin-Rufenach
et al., 1999). Theoretically, the ability of a4b7 to bind multiple
ligands should hinder the selectivity of lymphocyte trafficking
to different tissues that express MAdCAM-1 or VCAM-1. Inter-
estingly, lymphocytes activated in the gut have a propensity to
home back to the intestine where MAdCAM-1 is expressed but
are less likely to home to tissues expressing VCAM-1 (Johans-
son-Lindbom and Agace, 2007). However, the mechanism by
which integrin a4b7 selects between different binding ligands is
unknown.
Herein, we demonstrate that integrin a4b7 can be activated
by distinct chemokines in a ligand-specific manner to mediate
selective adhesion of lymphocytes to either MAdCAM-1 or
VCAM-1. Via distinct pathways, CCL25 and CXCL10 stimulate
different dephosphorylation of the b7 tails, which lead to distinct
binding patterns of talin and kindlin-3 to the b7 tail that induce
different activated forms of a4b7 to mediate lymphocyte adhe-
sion to either MAdCAM-1 or VCAM-1. Our findings provide a
mechanism for lymphocyte traffic control through the ligand-
specific regulation of integrin adhesion by different chemokines
under certain circumstance.evelopmental Cell 30, 61–70, July 14, 2014 ª2014 Elsevier Inc. 61
AC
E F
D
B
Figure 1. Chemokines Regulate Integrin a4b7-Mediated Lymphocyte
Adhesion to Different Ligands under Flow Conditions
(A and B) Adhesion of human PBLs toMAdCAM-1 (A) and VCAM-1 (B) at 1 dyn/
cm2 before and after chemokine stimulation. Cells were preincubated with
20 mg/ml AIIB2 to block a4b1, and then infused into the flow chamber; 1 mg/ml
Act-1was used to block a4b7-MAdCAM-1 interaction; 2 mg/ml HP2/1was used
to block the function of a4 integrin; 0.5 mM Mn
2+ was used as a control for
integrin activation.
(C–F) Adhesion of T lymphocytes (C), B lymphocytes (D), Jurkat T-b7/CXCR3
cells (E), and RPMI 8866-CXCR3 cells (F) to MAdCAM-1 and VCAM-1 at 1 dyn/
cm2 before and after chemokine stimulation. T lymphocytes, B lymphocytes,
and Jurkat T-b7/CXCR3 cells were preincubated with 20 mg/ml AIIB2 to block
a4b1, and then infused into the flow chamber.
Data represent themean ± SD (n = 3). *p < 0.05, **p < 0.01, ***p < 0.001, NS, not
significant (two-tailed Student’s t test; asterisk indicates the changes of total
adherent cells). See also Figure S1 and Movie S1.
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Integrin a4b7-Mediated Lymphocyte Adhesion to
Different Ligands Is Regulated by Distinct Chemokines
in a Ligand-Specific Manner
Chemokines have been shown to promote lymphocyte adhesion
to the endothelium by activating integrins (De Smedt et al.,
2001). To investigate the effect of different chemokines on integ-
rin a4b7-mediated lymphocyte adhesion to MAdCAM-1 and
VCAM-1 under flow conditions, we first studied the adhesion
of human peripheral blood lymphocytes (PBLs) on both sub-
strates at a wall shear stress of 1 dyn/cm2 in response to chemo-
kine stimulation using a parallel wall flow chamber as described
in the Experimental Procedures (Figures 1A and 1B; Movie S1
available online). A variety of lymphocyte-attracting chemokines
(Campbell et al., 1998), including CXCL10, CXCL12, CCL5,
CCL20, CCL21, and CCL25, were tested. Because PBLs ex-
press both a4b7 and a4b1 (Figure S1A), a4b1-VCAM-1 interaction
was disrupted by pretreating the cells with 20 mg/ml b1 blocking
antibody AIIB2 (Gui et al., 1996), which could efficiently block
the adhesion of a4b1-expressing Jurkat T cells to VCAM-1 (Fig-62 Developmental Cell 30, 61–70, July 14, 2014 ª2014 Elsevier Inc.ure S1B). Compared with the adhesion of PBLs to MAdCAM-1
and VCAM-1 before stimulation, activation of a4b7 with
0.5 mM Mn2+ greatly increased the number of PBLs that
adhered to both ligands. Strikingly, stimulation of PBLs with
CXCL12, CCL21, and CCL25 significantly increased PBL adhe-
sion to MAdCAM-1 but suppressed cell adhesion to VCAM-1.
Conversely, CXCL10, CCL5, and CCL20 increased cell adhesion
to VCAM-1 but suppressed cell adhesion to MAdCAM-1. Act-1,
an antibody that specifically blocks human a4b7-MAdCAM-1
interaction (Soler et al., 2009), completely abolished PBL adhe-
sion to MAdCAM-1. In addition, cells treated with human a4
blocking antibody HP2/1 did not adhere to both substrates
(Erle et al., 1994; Kamata et al., 1995). Similar results were ob-
tained when AIIB2-pretreated mouse splenic lymphocytes
(SPLs) were examined (Figure S1C). Either blocking a4 function
by antibody PS/2 or using b7-deficient SPLs abolished cell
adhesion to both ligands, suggesting the adhesion of SPLs is
a4b7-specific. Considering that lymphocyte adhesion was
most affected by CCL25 and CXCL10, we chose them as repre-
sentatives of the two groups of chemokines. PBLs that
were stimulated with soluble CCL25 and CXCL10 showed
adhesive behaviors similar to those observed with immobilized
chemokines (Figure S1D). Similar PBL adhesion patterns on
MAdCAM-1 and VCAM-1 substrates were observed in the
absence of a4b1 blockade (Figure S1E). Collectively, the data
demonstrate that activation of a4b7 by different chemokines re-
sults in selective adhesion of lymphocytes to either MAdCAM-1
or VCAM-1.
Approximately 94% of PBLs are T and B lymphocytes
(Figure S1A), and these cells may have different responses to
chemokine stimulation. Therefore, we isolated T and B lympho-
cytes from PBLs (Figure S1A) and examined cell adhesion to
MAdCAM-1 or VCAM-1 in flow in response to chemokine stimu-
lation (Figures 1C and 1D). Both T and B lymphocytes showed
adhesion behaviors similar to those of PBLs, indicating that
the chemokine-induced selective adhesion of lymphocytes to
MAdCAM-1 or VCAM-1 was not cell type dependent. To further
confirm that the chemokine-induced differential cell adhesion to
MAdCAM-1 or VCAM-1 was not due to the heterogeneity of
PBLs, we established human T cell line Jurkat T-b7/CXCR3
and B cell line RPMI 8866-CXCR3, which stably express a4b7,
CCR9 (CCL25 receptor), and CXCR3 (CXCL10 receptor) at a
homogeneous level (Figure S1A), and examined the effects of
CCL25 and CXCL10 on cell adhesion to MAdCAM-1 and
VCAM-1 in flow (Figures 1E and 1F). Both Jurkat T-b7/CXCR3
andRPMI 8866-CXCR3 cells showed adhesion behaviors similar
to those of human T/B lymphocytes and PBLs in response to
CCL25 and CXCL10 stimulations, indicating that CCL25 and
CXCL10 induced differential adhesion of same type of cells to
MAdCAM-1 or VCAM-1.
Ligand-Specific Activation of Integrin a4b7 Depends on
Distinct Chemokine Signaling
To investigate whether the ligand-specific activation of a4b7 by
different chemokines is due to the activation of distinct signaling
pathways, a series of kinase inhibitors was screened, and two
differential pathways that are related to the ligand-specific acti-
vation of a4b7 by CCL25 and CXCL10 were identified (Figure 2A;
Figure S2A). Inhibition of either PKCa/bI or p38a/bMAPK by their
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Figure 2. Ligand-Specific Activation of In-
tegrin a4b7 Depends on Distinct Signaling
Pathways Triggered by Different Chemo-
kines
(A) Effects of kinase inhibitors on chemokine-
induced adhesion of RPMI 8866-CXCR3 cells to
MAdCAM-1 and VCAM-1 at 1 dyn/cm2.
(B) Effect of dominant-negative kinase mutant on
chemokine-induced cell adhesion to MAdCAM-1
and VCAM-1 at 1 dyn/cm2. RPMI 8866-CXCR3
cells transiently expressing each mutant were
used.
(C) Effect of constitutively active kinase mutant
on cell adhesion to MAdCAM-1 and VCAM-1 at 1
dyn/cm2. RPMI 8866-CXCR3 cells transiently ex-
pressing each mutant were examined.
(D) Kinase activation over a 5 min after chemokine
stimulation. The phosphorylation of PKCa, p38a
MAPK, c-Src, and Syk from RPMI 8866-CXCR3
cells was determined by immunoblot analysis.
(E) Effects of kinase inhibitors on chemokine-
induced kinase activation in RPMI 8866-CXCR3
cells.
Data in (A)–(C) represent themean ± SD (n = 3). *p <
0.05, **p < 0.01, NS, not significant (two-tailed
Student’s t test; asterisk indicates the changes of
total adherent cells). See also Figure S2.
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vented CCL25-induced changes of adhesion of RPMI 8866-
CXCR3 cells (Figure 2A) and PBLs (Figure S2A) to MAdCAM-1
and VCAM-1, indicating that PKCa/bI and p38a/b MAPK are
essential to the ligand-specific regulation of a4b7-mediated
lymphocyte adhesion by CCL25. In addition, changes of cell
adhesion to MAdCAM-1 and VCAM-1 after CXCL10 stimulation
were inhibited by treatment with Src family kinase (SFK) inhibitor,
PP1, or Syk inhibitor, ER27319, demonstrating an essential role
of SFK and Syk in the ligand-specific regulation of a4b7-medi-
ated lymphocyte adhesion by CXCL10.
To confirm the roles of these kinases in the ligand-specific
activation of a4b7 by chemokines, dominant negative and
constitutively active mutants of each kinase were transiently
transfected into RPMI 8866-CXCR3 cells (Figures S2B and
S2C). Overexpression of the dominant-negative mutant of
PKCa (PKCa-DN), p38a MAPK (p38a-DN), c-Src (c-Src-DN), or
Syk (Syk-DN) showed the same effect on cell adhesion to
MAdCAM-1 and VCAM-1 as did the specific kinase inhibitors
(Figure 2B). In contrast, overexpression of the dominant-nega-
tive mutant of PKCbI (PKCbI-DN), p38b MAPK (p38b-DN), or
the other three members of SFK (Lck [Lck-DN], Fyn [Fyn-DN],
or Hck [Hck-DN]) hardly affected the chemokine-stimulated
cell adhesion to both ligands (Figure S2D). In addition, cells
with overexpression of the constitutively active form of PKCa
(PKCa-CA) or p38a MAPK (p38a-CA) showed similar adhesion
to MAdCAM-1 and VCAM-1 as cells stimulated with CCL25,
whereas overexpression of the constitutively active form of
c-Src (c-Src-CA) or Syk (Syk-CA) showed the same effect of
CXCL10 stimulation on cell adhesion to both ligands (Figure 2C).
Thus, PKCa/p38aMAPK and c-Src/Syk are involved in the stim-
ulation of differential cell adhesion to MAdCAM-1 and VCAM-1
by CCL25 and CXCL10, respectively.DTo further confirm that CCL25 and CXCL10 induced activation
of the kinases that were identified above, kinase phosphoryla-
tion in response to stimulation with soluble chemokines was
compared over 5 min in RPMI 8866-CXCR3 cells (Figure 2D)
and PBLs (Figure S2E). To exclude influence of ligand-binding
induced integrin outside-in signaling, no integrin ligand was
included in the chemokine-stimulation system. As expected,
CCL25 stimulation specifically increased PKCa and p38a MAPK
phosphorylation, but did not increase c-Src or Syk phosphoryla-
tion. On the contrary, CXCL10 stimulation increased c-Src and
Syk phosphorylation, but did not increase PKCa or p38a MAPK
phosphorylation. Inhibition of p38aMAPKbySB-203580 inhibited
the CCL25-stimulated phosphorylation of both p38a MAPK and
PKCa (Figure 2E; Figure S2F). In contrast, inhibition of PKCa by
Go¨ 6976 inhibited the phosphorylation of PKCa, but not p38a
MAPK. The data suggest that PKCa is located downstream of
p38aMAPK. Inhibitionofc-SrcbyPP1 inhibited theCXCL10-stim-
ulated activation of both c-Src and Syk (Figure 2E; Figure S2F).
However, theSyk inhibitor,ER27319,only inhibitedSykactivation.
These data suggest that Syk is located downstream of c-Src.
Collectively, the results demonstrate that CCL25 promotes
a4b7-mediated cell adhesion to MAdCAM-1 and suppresses
adhesion to VCAM-1 through activation of the p38a MAPK/
PKCa pathway. CXCL10 stimulates the opposite effect by acti-
vating the c-Src/Syk axis.
Different Chemokine Signaling Pathways Lead to
Distinct Binding Patterns of Talin and Kindlin-3 to the
b7 Tail
The activation of GPCR signaling by chemokines regulates the
binding of intracellular effector proteins to integrin tails, which trig-
gers integrin’s activation through inside-out signaling (Hogg et al.,
2011). To investigate the effect of chemokine signaling on theevelopmental Cell 30, 61–70, July 14, 2014 ª2014 Elsevier Inc. 63
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Figure 3. Different Chemokines Induce Distinct Integrin b7 Tail Phosphorylation and Talin/Kindlin-3 Binding
(A and B) Coimmunoprecipitation of talin/kindlin-3 with b7 fromRPMI 8866-CXCR3 cells before and after chemokine stimulation (A) or withmodified talin/kindlin-3
expression, including talin overexpression (Talin O/E) and talin overexpression combined with kindlin-3 knockdown (Talin O/E and Kindlin-3 KD; B).
(C) Effect of Talin O/E or Talin O/E and Kindlin-3 KD on RPMI 8866-CXCR3 cell adhesion to MAdCAM-1 and VCAM-1 at 1 dyn/cm2.
(D) Tyr and Ser/Thr phosphorylation of b7 in RPMI 8866-CXCR3 cells before and after chemokine stimulation.
(E) Effects of dominant-negative kinase mutant on Tyr and Ser/Thr phosphorylation of b7 in RPMI 8866-CXCR3 cells before and after chemokine stimulation.
(F) Adhesion of Jurkat T cells expressing WT and mutant human b7 to MAdCAM-1 and VCAM-1 at 1 dyn/cm
2. Cells were preincubated with 20 mg/ml AIIB2, and
then infused into the flow chamber.
(G) Coimmunoprecipitation of talin/kindlin-3 with b7 from Jurkat T cells expressing WT and mutant human b7.
(H) Tyr and Ser/Thr phosphorylation of b7 in Jurkat T cells expressing WT and mutant human b7.
Data in (C) and (F) represent the mean ± SD (n = 3). *p < 0.05, **p < 0.01, NS, not significant (two-tailed Student’s t test; asterisk indicates the changes of total
adherent cells). See also Figure S3.
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the major effector proteins that bind to the integrin b tails to regu-
late integrin activation (Moser et al., 2009). Kindlin-3 was selected
from the three members of the kindlin family because it is ex-
pressed in cells of hematopoietic origin (Moser et al., 2008). The
binding of talin and kindlin-3 to a4b7 was determined by coimmu-
noprecipitation of these two proteins with a4b7 in RPMI 8866-
CXCR3 cells. Interestingly, CCL25 and CXCL10 stimulated
different patterns of interaction between the b7 tail and talin or
kindlin-3 (Figure 3A). CCL25 stimulation markedly increased talin
binding to a4b7 but dramatically reduced kindlin-3 binding
compared with nonstimulated cells. However, CXCL10 stimula-
tion increased talin binding but hardly changed kindlin-3 binding.
The data suggest that the intracellular signaling pathways that are
activated by CCL25 and CXCL10 induce distinct binding patterns
of talin and kindlin-3 to a4b7, whichmay result in differential integ-
rin activation. To test this hypothesis, we overexpressed talin to64 Developmental Cell 30, 61–70, July 14, 2014 ª2014 Elsevier Inc.increase talin binding to the b7 tail, which mimicked the
CXCL10-induced talin/kindlin-3 binding pattern (Figure 3B). Addi-
tionally, talin overexpression combined with kindlin-3 knockdown
mimicked the CCL25-induced talin/kindlin-3 binding pattern (Fig-
ure 3B). As expected, cells that overexpressed talin showed
similar adhesion patterns onMAdCAM-1 andVCAM-1 substrates
as cells that were stimulated with CXCL10 (Figure 3C). Cells that
overexpressed talin and had kindlin-3 knocked down showed
similar adhesion patterns as cells that were stimulated with
CCL25 (Figure 3C).
Different Chemokines Induce Distinct Phosphorylation
States of the b7 Tail
The binding of talin and kindlin to integrins is regulated by integrin
b tail phosphorylation. Talin binds the NPxY motif on the b tail to
activate integrins, and phosphorylation of the Tyr in this motif in-
hibits talin binding (Sakai et al., 2001). Kindlin binds the distal
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2009). Phosphorylation of an Ser/Thr-rich region between the
NPxY/NxxY motifs is important for integrin to bind kindlin (Moser
et al., 2008). To investigate whether phosphorylation of the NPxY
and Ser/Thr-rich motifs in the b7 tail is regulated by different che-
mokines, we compared Tyr and Ser/Thr phosphorylation in the
b7 tail in response to chemokine stimulations. CCL25 stimulation
dramatically decreased the phosphorylation of Tyr and Ser/Thr
residues in b7, whereas CXCL10 stimulation only lowered the
Tyr phosphorylation (Figure 3D). The results are consistent with
the differential binding of talin and kindlin-3 to the b7 tail in
response to chemokine stimulations. In addition, overexpression
of dominant negative mutant PKCa (PKCa-DN) or p38a MAPK
(p38a-DN) inhibited the downregulation of Tyr and Ser/Thr phos-
phorylation in b7 by CCL25 (Figure 3E), and overexpression of
dominant-negative mutant c-Src (c-Src-DN) and Syk (Syk-DN)
prevented the decrease of Tyr phosphorylation in b7 upon
CXCL10 stimulation (Figure 3E), indicating that the CCL25- and
CXCL10-induced distinct phosphorylation states of b7 are
dependent on the activation of p38a MAPK/PKCa and c-Src/
Syk pathways, respectively.
Next, we mutated Tyr778 in NPxY motif and Thr782-784 in the
Ser/Thr-rich region on the b7 tail, and stably expressed WT or
mutant a4b7 in Jurkat T cells (Figure S3A), which lack endoge-
nous b7. Y778F mutation was made to abolish phosphorylation
of the Tyr in NPxYmotif, which is expected to increase talin bind-
ing to the b7 tail. As expected, Y778F showed similar effect of
CXCL10 stimulation on cell adhesion to MAdCAM-1 and
VCAM-1, suggesting Y778 dephosphorylation is important for
the regulation by CXCL10 (Figure 3F). Mutation of the Ser/Thr-
rich region to Ala (T782A, T783A, T784A) is expected to interrupt
kindlin-3 binding to integrin b tails (Moser et al., 2008). Except
for T784A, T782A, T783A, and T782A/T783A double mutation
showed a similar effect of CCL25 stimulation on cell adhesion
to both ligands, suggesting the dephosphorylation of T782 and
T783 is important for regulation by CCL25 (Figure 3F). Notably,
the addition of the Y778F mutation to T782A/T783A double mu-
tation enhanced talin binding and decreased kindlin-3 binding
to the b7 tail (Figure 3G), which further enhanced the effect
of T782A/T783A double mutation on the cell adhesion to both
ligands (Figure 3F), suggesting the increased talin binding can
enhance the effect of decreased kindlin-3 binding on cell
adhesion. Thus, b7 Y778F/T782A/T783A triple mutation or
Y778F single mutation induced similar talin/kindlin-3 binding
and cell adhesion that were stimulated by CCL25 or CXCL10,
respectively (Figures 3F and 3G). Y778F/T782A/T783A triple
mutation almost abolished the basal Tyr and Ser/Thr phosphor-
ylation in b7, suggesting the Tyr and Ser/Thr phosphorylation sig-
nals in b7 are mainly from Y778 and T782/T783 (Figure 3H).
We next investigated whether the decreased phosphorylation
of b7 is due to the dephosphorylation of Tyr and Ser/Thr by phos-
phatases. It is reported that both PKC and Syk contribute to the
activation of Tyr phosphatase Cdc25 (Hirano et al., 2000; Yu
et al., 2004). In addition, PKC also contributes to the activation
of Ser/Thr phosphatase PP2B (LaFayette et al., 2010). Our data
showed that blocking either PP2B or Cdc25 with their specific
inhibitors, Cypermethrin or NSC-663284, inhibited the CCL25-
induced Ser/Thr or Tyr dephosphorylation of b7 (Figure 4A)
and diminished the changes of cell adhesion to MAdCAM-1Dand VCAM-1 induced by CCL25 stimulation (Figure 4B).
Moreover, inhibition of Cdc25 by NSC-663284 prevented the
CXCL10-induced Tyr dephosphorylation in b7 (Figure 4A) and
the changes of cell adhesion induced by CXCL10 (Figure 4B).
To further confirm the results, the dominant-negative mutants
of PP2B and lymphocyte-expressing Cdc25 isoforms (Cdc25A
and Cdc25C) were generated and then transiently transfected
into cells (Figure S4A). Overexpression of the dominant-negative
mutants of either PP2B (PP2B-DN) or Cdc25A (Cdc25A-DN), but
not Cdc25C (Cdc25C-DN), prevented the changes of cell adhe-
sion to both ligands induced by CCL25 (Figure 4C). Moreover,
overexpression of Cdc25A-DN also inhibited the changes of
cell adhesion induced by CXCL10. Consistently, coexpression
of the active mutants of PP2B (PP2B-CA) and Cdc25A
(Cdc25A-CA) showed the similar effect of CCL25 stimulation
on cell adhesion to MAdCAM-1 and VCAM-1 (Figure 4D; Fig-
ure S4B). Overexpression of Cdc25A-CA alone showed a similar
effect of CXCL10 stimulation on cell adhesion to both ligands.
Collectively, these data demonstrate that CCL25-stimulated
cell adhesion to MAdCAM-1 and VCAM-1 depends on both
PP2B and Cdc25A, and CXCL10-induced cell adhesion only re-
lies on Cdc25A. Thus, the chemokine-induced ligand-specific
activation of a4b7 depends on the differential dephosphorylation
of Ser/Thr and Tyr in b7 by PP2B and Cdc25A, respectively.
The chemokine-induced dephosphorylation of b7 implies that
b7 integrin is phosphorylated at high stoichiometry in the resting
state. Thus, we examined the stoichiometry of b7 phosphoryla-
tion in nonstimulated RPMI 8866-CXCR3 cells (Ratnakumar
et al., 2009). The results showed that approximately 40% or
50% of the cell surface b7 integrins were Tyr or Ser/Thr phos-
phorylated before chemokine stimulation (Figures 4E and 4F).
In addition, b7 showed much higher level of Tyr and Ser/Thr
phosphorylation than b2 in resting state (Figures 4G and 4H).
Thus, the data demonstrate that b7 integrin is hyperphosphory-
lated in the nonstimulated state.
Distinct Chemokine Signaling Triggers Different
MAdCAM-1 and VCAM-1 Binding to a4b7
Next, we examined the binding of soluble MAdCAM-1 or
VCAM-1 to a4b7 in response to chemokine stimulation (Fig-
ure 5A). Compared with nonstimulated RPMI 8866-CXCR3 cells,
CCL25 stimulation significantly increased MAdCAM-1 binding
and decreased VCAM-1 binding. In contrast, CXCL10 stimula-
tion showed opposite results. Treatment with Mn2+ maximally
enhanced the binding of both ligands. Act-1 specifically blocked
MAdCAM-1 binding. In addition, blocking a4 by HP2/1 abolished
binding of both ligands. These soluble ligand binding results are
consistent with the results of cell adhesion in flow in response
to chemokine stimulation. We next examined the effect of talin
overexpression and kindlin-3 knockdown on soluble ligand bind-
ing to a4b7 (Figure 5B). Consistently, cells that overexpressed
talin, which mimicked the CXCL10-induced talin/kindlin-3 bind-
ing pattern, showed similar soluble ligand binding results as cells
that were stimulated with CXCL10. In addition, cells that overex-
pressed talin and had kindlin-3 knocked down showed similar
results as cells that were stimulated with CCL25.
Taken together, CCL25 and CXCL10 stimulate different bind-
ing patterns of talin and kindlin-3 to the b7 tail, which induce dif-
ferential binding of MAdCAM-1 and VCAM-1 to a4b7.evelopmental Cell 30, 61–70, July 14, 2014 ª2014 Elsevier Inc. 65
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Figure 4. Chemokine-Induced Ligand-Specific Activation of a4b7
Depends on the Dephosphorylation of the b7 Tail by Phosphatases
(A) Effects of Ser/Thr and Tyr phosphatase inhibitors on b7 phosphorylation in
RPMI 8866-CXCR3 cells before and after chemokine stimulation.
(B) Effects of phosphatase inhibitors on the chemokine-induced
adhesion of RPMI 8866-CXCR3 cells to MAdCAM-1 and VCAM-1 at 1
dyn/cm2.
(C) Effects of dominant-negative PP2B, Cdc25A, and Cdc25C mutants on the
chemokine-induced adhesion of RPMI 8866-CXCR3 cells to MAdCAM-1 and
VCAM-1 at 1 dyn/cm2.
(D) Effects of constitutively active PP2B and Cdc25A mutants on RPMI 8866-
CXCR3 cell adhesion to MAdCAM-1 and VCAM-1 at 1 dyn/cm2.
(E) The stoichiometry of b7 phosphorylation. Tyr- or Ser/Thr-phosphorylated
proteins from the membrane of nonstimulated RPMI 8866-CXCR3 cells were
immunoprecipitated by anti-phosphotyrosine or anti-phosphoserine/threo-
nine antibody. The same amount of the input (IP-pre), IP, and remaining lysate
after IP (IP-post) were run on SDS-PAGE. b7 integrins were blotted with
monoclonal antibodies against human b7. Tyr- or Ser/Thr-phosphorylated
proteins were blotted as controls.
(F) Quantification of Tyr or Ser/Thr phosphorylation stoichiometry of b7 ac-
cording to (E).
(G) Phosphorylation levels of b2 and b7 in nonstimulated RPMI 8866-CXCR3
cells. b2 and b7 were immunoprecipitated from RPMI 8866-CXCR3 cells. The
same amount of b2 and b7 was loaded on SDS-PAGE and confirmed by silver
staining (Input). Tyr and Ser/Thr phosphorylation in b2 and b7 subunits were
detected with immunoblot.
(H) Quantification of Tyr and Ser/Thr phosphorylation levels of b2 and b7
according to (G). The phosphorylation levels of b2 and b7 were normalized to
the input.
Developmental Cell
Chemokines Regulate Integrin Ligand Specificity
66 Developmental Cell 30, 61–70, July 14, 2014 ª2014 Elsevier Inc.Distinct Chemokine Signaling Stimulates a4b7 to
Regulate the Tissue Specificity of Lymphocyte Homing
in Vivo
a4b7 plays a critical role in tissue-specific lymphocyte homing to
mLNs and pLNs, where MAdCAM-1 and VCAM-1 are highly ex-
pressed, respectively (Cording et al., 2014). Our study showed
that CCL25 stimulation simultaneously enhanced the talin bind-
ing and reduced kindlin-3 binding to the b7 tail, which increased
the binding of a4b7 toMAdCAM-1 and decreased a4b7 binding to
VCAM-1. In contrast, CXCL10 only enhanced talin binding to the
b7 tail, which induced opposite cell adhesion to both ligands.
Thus, talin overexpression combined with kindlin-3 knockdown
should promote lymphocyte homing to mLNs and inhibit
lymphocyte homing to pLNs, whereas talin overexpression alone
should have opposite effect. We thenmodified talin and kindlin-3
expression accordingly in SPLs and studied the effect on
lymphocyte homing to mLNs and pLNs in mice. SPLs with talin
overexpression alone (Talin O/E-SPLs) or simultaneous knock-
down of kindlin-3 (Talin O/E and Kindlin-3 KD-SPLs; Figure S6A)
were labeled with CFSE. SPLs that were transfected with vector
alone (Vector control-SPLs) or along with scramble shRNA
(Scramble RNA and Vector control-SPLs) were labeled with
DID as a control. Equal numbers of CFSE-SPLs and DID-SPLs
were mixed and then intravenously injected into C57BL/6J
mice. Lymphoid organs were isolated 30 min after injection.
The number of CFSE- or DID-labeled lymphocytes in mLNs
and pLNs was determined with flow cytometry (Table S1), and
then the homing index was determined (Figures 6A and 6B).
Compared with Scramble RNA and Vector control-SPLs, Talin
O/E and Kindlin-3 KD-SPLs homed significantly more to mLNs
but less to pLNs (Figure 6A). In contrast, talin overexpression
alone decreased SPL homing to mLNs but enhanced SPL hom-
ing to pLNs (Figure 6A). b7-deficient Talin O/E and Kindlin-3 KD-
SPLs and Talin O/E-SPLs showed no preference for homing to
pLNs and mLNs (Figure 6B), indicating that the distinct homing
specificities are b7-dependent. In addition, the effects of different
talin/kindlin expression on the adhesion of WT and b7-deficient
SPLs to MAdCAM-1 and VCAM-1 in flow were examined (Fig-
ure S6B). The in vitro cell adhesion results are consistent with
the in vivo data. Thus, these data demonstrate that CCL25-
and CXCL10-induced differential talin/kindlin-3 binding to the
b7 tail regulates the specificity of lymphocyte homing to tissues
that express MAdCAM-1 or VCAM-1 in vivo.
Next, we investigated whether the ligand-specific activation of
a4b7 by CCL25 or CXCL10 regulates the tissue specificity of
lymphocyte homing to mLNs and pLNs in mice. The competitive
in vivo homing of CCL25 or CXCL10-stimulated SPLs versus
nonstimulated SPLs was examined. Because the effects of
CCL25 and CXCL10 on a4b7-mediated adhesion of SPLs to
both ligands can persist for at least 1 hr (Figure S6C), lymphoid
organs were isolated 30 min after injection and the homing
indices for different chemokine stimulations were then deter-
mined. Compared with the nonstimulated SPLs, CCL25 stimula-
tion significantly increased SPL homing to mLNs, but decreasedData represent themean ± SD (n = 3). *p < 0.05, **p < 0.01, ***p < 0.001, NS, not
significant (two-tailed Student’s t test; asterisk in B–D indicates the changes of
total adherent cells). See also Figure S4.
AB
Figure 5. Chemokines Induce Different Affinities of Integrin a4b7
(A and B) Binding of soluble MAdCAM-1 and VCAM-1 to RPMI 8866-CXCR3
cells before and after chemokine stimulation (A) or with modified talin/kindlin-3
expression (B); 0.5mMMn2+ was used as a control for integrin activation; 1 mg/
ml Act-1 and 2 mg/ml HP2/1 were used to block the human a4b7-MAdCAM-1
interaction and the function of a4 integrin, respectively.
Data represent the mean ± SD (n = 3). **p < 0.01, ***p < 0.001, NS, not sig-
nificant (two-tailed Student’s t test). See also Figure S5.
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decreased SPL homing to mLNs but enhanced SPL homing to
pLNs (Figure 6C). b7-deficient SPLs did not show any preference
for homing to mLNs or pLNs after chemokine stimulation
(Figure 6D), indicating that the increased homing specificity of
lymphocytes to mLNs and pLNs by CCL25 or CXCL10 stimula-
tion is a4b7-dependent. In addition, inhibition of either PKCa or
p38aMAPK abolished the CCL25-induced change of SPL hom-
ing to mLNs and pLNs (Figures 6E and 6F). And inhibition of
c-Src or Syk specifically abolished the effects of CXCL10 stimu-
lation on SPL homing to mLNs and pLNs (Figures 6G and 6H).
Thus, CCL25 and CXCL10 regulate the tissue specificity of
lymphocyte homing to mLNs and pLNs in vivo, which are depen-
dent on p38a MAPK/PKCa and c-Src/Syk signaling pathways,
respectively.
To confirm that the chemokine-induced a4b7 ligand specificity
switch is deployed in vivo to alter lymphocyte homing in a phys-
iologically significant manner, we investigated the lymphocyte
homing tomLNs and pLNs inmice following viral infection, which
has been shown to induce CXCL10 expression (Borgland et al.,
2000). Wild-type, b7-deficient and CXCR3-deficient mice were
intravenously injected with adenovirus, and CXCL10 expression
was significantly increased in mLNs and pLNs at transcription
level 6 hr after virus injection compared with PBS-injected con-
trol mice (Figure S6D). Then, pLNs and mLNs were isolated
and the number of lymphocytes was determined (Figure S6E).
Compared with PBS control mice, the number of lymphocytes
significantly increased in pLNs but decreased in mLNs in viral
infection mice. In contrast, the number of lymphocytes in
mLNs and pLNs showed no significant change in b7-deficient
or CXCR3-deficient mice after viral infection. Thus, viral infec-Dtion-induced CXCL10 expression promotes lymphocyte homing
to pLNs but suppresses lymphocyte homing to mLNs in vivo,
which is b7- and CXCR3-dependent. Next, we examined the
homing of lymphocytes to pLNs and mLNs in viral infection
mice and PBS control mice. Compared with PBS control mice,
the number of wild-type (WT) SPLs significantly increased in
pLNs, but decreased in mLNs in viral infection mice (Figures
S6F and S6G). However, there was no difference in homing of
b7-deficient or CXCR3-deficient SPLs to pLNs and mLNs be-
tween viral infection and PBS control mice (Figures S6F and
S6G), indicating the effect of CXCL10 on lymphocyte homing
to pLNs and mLNs is b7- and CXCR3-dependent. Collectively,
viral infection-induced CXCL10 expression enhances lympho-
cyte homing to pLNs, but suppresses lymphocyte homing to
mLNs in mice, suggesting that CXCL10 regulates lymphocyte
homing to distinct tissues in vivo by switching the ligand speci-
ficity of a4b7.
DISCUSSION
Our study demonstrates the switch of integrin ligand-specificity
by distinct chemokine signaling and its underlying molecular
mechanism. These findings reveal a potential mechanism for
maintaining the specificity of lymphocyte homing to different tis-
sues through the ligand-specific activation of integrins by
different chemokines (Figure 6; Figure S6), which could be an
important complement to the current model of lymphocyte tis-
sue-specific homing.
In addition to a4b7, lymphocytes also express a4b1, which
binds VCAM-1 and contributes to lymphocyte homing to pLNs
(Santamaria Babi et al., 1995). Thus, we investigated the effects
of CCL25 and CXCL10 on cell adhesion to MAdCAM-1 and
VCAM-1 without blocking a4b1 (Figure S1E). Consistent with
the fact that a4b1 only binds VCAM-1, we did observe an in-
crease of adherent PBLs to immobilized VCAM-1 (Figure S1E)
compared with the cells that a4b1 function was blocked (Fig-
ure 1B). Notably, the CCL25- and CXCL10-induced distinct
cell adhesion to VCAM-1 remained before and after blocking
a4b1. Furthermore, we examined the effects of CCL25 and
CXCL10 stimulations on SPL homing to pLNs and mLNs with
(Figure S6H) or without blocking a4b1 (Figures 6C and 6D).
Consistent with the fact that VCAM-1 highly expressed in
pLNs but not in mLNs (Mori et al., 1999), blocking a4b1
decreased the number of SPLs that homed to pLNs, but hardly
affected cell homing to mLN (Table S1). The CCL25 and
CXCL10 stimulation-induced distinct homing patterns of SPLs
to pLNs and mLNs were unchanged before and after blocking
a4b1 (Figure S6H). Taken together, a4b1 only contributes to the
homing of lymphocytes to VCAM-1-expressing pLNs, but not
MAdCAM-1-expressing mLNs. The presence of a4b1 could
increase the total number of cells homed to pLNs, but did not
change the CCL25- and CXCL10-induced distinct adhesion
patterns that depend on the function of a4b7. We also exam-
ined a4b1-mediated cell adhesion to VCAM-1 in responses to
different chemokines using b7-deficient SPLs (Figure S1F). Un-
like suppressing the a4b7-medaited cell adhesion to VCAM-1,
CXCL12, CCL21, or CCL25 stimulation did not change a4b1-
mediated cell adhesion to VCAM-1. CXCL10, CCL20, or CCL5
stimulation increased cell adhesion to VCAM-1, which wasevelopmental Cell 30, 61–70, July 14, 2014 ª2014 Elsevier Inc. 67
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Figure 6. Different Chemokine Signaling
Regulates Tissue-Specific Homing of Lym-
phocytes
(A and B) In vivo competitive homing ofWT SPLs (A)
or b7-deficient SPLs (B) with talin overexpression
combined with kindlin-3 knockdown (Talin O/E and
Kindlin-3 KD-SPLs) or talin overexpression alone
(Talin O/E-SPLs). The ratios of Talin O/E and
Kindlin-3 KD-SPLs over Scramble RNA and Vector
control-SPLs or Talin O/E-SPLs over Vector con-
trol-SPLs that homed to pLNs and mLNs in C57BL/
6J mice are shown.
(C and D) In vivo competitive homing of WT SPLs
(C) or b7-deficient SPLs (D) before and after che-
mokine stimulation. The ratio of chemokine-simu-
lated SPLs over nonsimulated SPLs that homed to
pLNs and mLNs in C57BL/6J mice is shown.
(E–H) Effect of kinase inhibitor on tissue-specific
homing of lymphocytes in mice before and
after chemokine stimulation. WT SPLs were pre-
treated with Go¨6976 (E), SB-203580 (F), PP1 (G),
or ER27319 (H) before chemokine stimulation.
The ratio of chemokine-simulated SPLs over non-
simulated SPLs that homed to pLNs and mLNs
in C57BL/6J mice is shown.
Data represent the mean (n = 6). ***p < 0.001, NS,
not significant (two-tailed Student’s t test). See also
Figure S6 and Table S1.
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adhesion.
Our data showed that CXCL12, CCL21, or CCL25 promoted
lymphocyte adhesion to MAdCAM-1 but suppressed cell adhe-
sion to VCAM-1. In contrast, CXCL10, CCL5, or CCL20 showed
an opposite effect on lymphocyte adhesion to both ligands.
CCL25, CXCL12, or CCL21 specifically increased the phosphor-
ylation of PKCa and p38a MAPK, whereas CXCL10, CCL20, or
CCL5 specifically increased the phosphorylation of c-Src and
Syk (Figure 2D; Figures S2E and S2G). Thus, the two groups of
chemokines activated the p38a MAPK/PKCa and c-Src/Syk
pathways respectively, which differentially activated a4b7 and re-
sulted in different binding affinity to MAdCAM-1 and VCAM-1.
As a control for the opposite regulatory effects of CCL25 and
CXCL10, stimulation of cells with CCL25 and CXCL10 at the
same time did not change cell adhesion to MAdCAM-1 and
VCAM-1 when compared with nonstimulated cells (Figure S1G).
The data suggest that costimulation by CCL25 and CXCL10
leads to the counteraction of opposite regulatory effects of
CCL25 and CXCL10. Thus, the net regulatory effect on cell adhe-
sion is compromised in comparison with the results of cells stim-
ulated by individual chemokine.
Filamin has been shown to compete with talin for binding
to integrin b tails (Kiema et al., 2006). However, simultaneous
increase of filamin and talin binding to the b7 tail was observed68 Developmental Cell 30, 61–70, July 14, 2014 ª2014 Elsevier Inc.after overexpression of dominant active
RSK2 (Gawecka et al., 2012), suggesting
that both filamin and talin can associate
with the b7 tail without competition under
certain conditions. Previous studies have
shown that binding of filamin to integrinis inhibited by the phosphorylation of the Ser/Thr-rich region in
the b tail (Legate and Fa¨ssler, 2009). Because kindlin binding
to integrin depends on the phosphorylation of this Ser/Thr-rich
region, kindlin might compete with filamin for binding to integrin
b tails. Here, we monitored filamin binding to b7 in response to
chemokine stimulation (Figures S3B and S3C). CXCL10 stimula-
tion simultaneously increased talin binding and reduced filamin A
binding to a4b7, but hardly affected kindlin-3 binding, suggesting
filamin A might compete with talin for binding to b7 under the
conditions induced by CXCL10. Interestingly, CCL25 stimulation
markedly increased both the binding of filamin A and talin, but
dramatically reduced kindlin-3 binding to a4b7, suggesting
a potential competition between filamin A and kindlin-3 for bind-
ing to b7 under the CCL25-induced condition. Thus, our data
suggest that filamin can compete with either kindlin-3 or talin
for binding to b7 tail under different circumstances.
Kindlin-3 is believed to be essential for the activation of b1 and
b3 integrins (Lefort and Ley, 2012; Moser et al., 2008). Knock-
down of kindlin-3 is sufficient to block the b2-mediated cell adhe-
sion to ICAM-1 (Figures S3D–S3F). Additionally, the requirement
of kindlin-3 for integrin aLb2 and a4b1 to bind ligands is only crit-
ical when integrin ligand level is low, but of less importance when
integrin ligand level is high (Moretti et al., 2013), suggesting that
kindlin-3 has distinct regulatory functions under different condi-
tions. Interestingly, this study has shown that talin binding alone
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different effects on aLb2 conformation (Lefort et al., 2012), which
is consistent with our finding that distinct talin and kindlin-3 bind-
ing patterns induce differential activation of a4b7 and result in
different binding of MAdCAM-1 and VCAM-1 to a4b7.
Integrin affinity and valency are both important for integrin-
mediated cell adhesion. Therefore, we examined a4b7 subcellu-
lar distribution in response to chemokine stimulation (Figure S5).
Compared with no discernable clustering of a4b7 on nonstimu-
lated PBLs, obvious clusters of a4b7 were induced by antibody
crosslinking (Kim et al., 2004). CCL25 and CXCL10 induced
similar weak clustering of a4b7 on the surface of PBLs. Thus,
CCL25 and CXCL10 do not induce different subcellular distribu-
tion of a4b7.
Leukocyte adhesion deficiency (LAD) is a very rare genetic
disorder that affects the body’s immune system. The hallmarks
of LAD are defects in the leukocyte adhesion process, marked
leukocytosis, and recurrent infections (Akbari and Zadeh,
2001). Among the three general genotypes of LAD, LAD-III is
due to the mutation in the kindlin3 gene (Svensson et al.,
2009). The kindlin-3 mutation leads to the deficiency of its bind-
ing to integrin. Clinical cases showed that some patients with
LAD exhibited certain signs and symptoms suggestive of a
Crohn’s disease-like disorder (D’Agata et al., 1996), suggesting
the aberrant lymphocytes accumulate in the gut in particular
cases of LAD (possible LAD-III). These data are consistent
with our findings that decreased kindlin-3 binding together with
increased talin binding to the b7 tail enhanced lymphocyte adhe-
sion to MAdCAM-1 and homing to the gut.
EXPERIMENTAL PROCEDURES
Flow Chamber Assay
A polystyrene Petri dish was coated with 20 ml of MAdCAM-1/Fc (10 mg/ml) or
VCAM-1/Fc (10 mg/ml) alone or with chemokines (2 mg/ml) in coating buffer
(PBS, 10 mM NaHCO3, pH 9.0) for 1 hr at 37
C followed by blocking with
2% BSA in coating buffer for 1 hr at 37C. Cells were diluted to 1 3 106
cells/ml in HBSS (10mM HEPES, 1 mM Ca2+/Mg2+) and immediately perfused
through the flow chamber at a constant flow of 1 dyn/cm2. For the soluble
chemokine stimulation, cells were prestimulated for the indicated times with
soluble chemokines (0.5 mg/ml) at room temperature before being perfused
into the flow chamber. For the kinase or phosphatase inhibition, cells were
pretreated with 1 mM Go¨6976 for 1 hr at 37C; or 10 mM SB-203580, 10 mM
PP1, or 10 mM ER27319 for 30 min at 37C, respectively.
All adhesive interactions between the flowing cells and the coated sub-
strates were determined by manually tracking the motions of individual cells
for 1 min as previously described (Ebisuno et al., 2010). The motion of each
adherent cell was monitored for 10 s following the initial adhesion point, and
two categories of cell adhesion were defined. Adhesion was defined as rolling
adhesion if the adherent cells were followed by rolling motions R 5 s with a
velocity of at least 1 mm/s (for PBLs and SPLs) or 2 mm/s (for Jurkat T-b7/
CXCR3 and RPMI 8866-CXCR3 cells due to the larger cell size), whereas a
firmly adherent cell was defined as a cell that remained adherent and station-
ary for at least 10 s.
In Vivo Competitive Lymphocyte Homing
SPLs were isolated fromWTmice (C57BL/6J mice, from SLAC) or b7-deficient
mice (Itgb7/ C57BL/6J mice, from Jackson Laboratory). In Figures 6A and
6B, Talin O/E and Kindlin-3 KD SPLs (or Talin O/E SPLs) and Scramble RNA
and Vector control SPLs (or Vector control SPLs) were labeled with CFSE
and DID, respectively. In Figures 6C–6H, chemokine-stimulated SPLs and
nonstimulated SPLs were labeled with CFSE and DID, respectively. Equal
numbers (13 107) of CFSE- or DID-labeled cells are mixed and injected intra-Dvenously into recipient mice via the tail vein. After 30 min, the recipient mice
were killed, and lymphocytes from pLNs andmLNs were harvested. The abso-
lute cell numbers were determined by flow cytometry (FACS Calibur, BD), and
the ratios of CFSE- and DID-labeled cells in pLNs or mLNs were calculated. In
Figures 6E–6H, SPLs were pretreated with kinase inhibitors, then stimulated
with chemokines.
Animals
TheWT C57BL/6J mice were obtained from SLAC. The b7- deficient (Itgb7
/)
and CXCR3-deficient (Cxcr3/) C57BL/6Jmice were obtained from the Jack-
son Laboratory. The genotype of knockout mice was verified with PCR ampli-
fication (Taq DNA Polymerase, Vazyme). All experimental animal procedures
were approved by the Institutional Animal Care and Research Advisory Com-
mittee of the Institute of Biochemistry and Cell Biology, Shanghai Institutes for
Biological Sciences, Chinese Academy of Sciences.
Statistical Analysis
Statistical significance was determined by two-tailed Student’s t test using
PRISM software (version 5.00, GraphPad Software). The resulting p values
are indicated as follows: NS, p > 0.05; *, 0.01 < p < 0.05; **, 0.001 < p <
0.01; ***, p < 0.001. Data represent themean ± SD of at least three independent
experiments. Western blot results showed the representative images from
three independent experiments.
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